Tag: Bureau of Competition

Displaying 1 - 20 of 760 results.

Pages

The Federal Trade Commission will co-host a Twitter chat with the office of Nebraska Gov. Pete Ricketts at 3 p.m. ET today on the FTC’s new Economic Liberty Task Force, the first major policy initiative of Acting FTC Chairman Maureen K. Ohlhausen.
Following the decision earlier this month by Advocate Health Care Network and NorthShore University HealthSystem to abandon their proposed merger, the Federal Trade Commission has dismissed its case challenging the transaction before the Commission’s administrative trial process.FTC Acting...
New web pages on the Federal Trade Commission’s website will highlight the work of the agency’s new Economic Liberty Task Force, which Acting Chairman Maureen K. Ohlhausen announced as her first major policy initiative for the agency.
Federal Trade Commission staff submitted a comment to the Ohio State Senate on proposed legislation that would broaden dental hygienists’ ability to work without a supervising dentist on-site, and provide for the licensure of dental therapists, a relatively new type of “mid-level” provider who...
“The FTC is delighted with today’s district court ruling, which enjoined this merger, and the parties’ subsequent decision to abandon the transaction,” said Tad Lipsky, Acting Director of the Federal Trade Commission’s Bureau of Competition. “Advocate and NorthShore’s merger would likely have...
This is National Consumer Protection Week, a week set aside every year to help consumers know their rights and make well-informed choices in the marketplace.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that OFTACOOP, a Puerto Rican ophthalmologist cooperative, unlawfully orchestrated an agreement among competing ophthalmologists to refuse to deal with a health plan, MCS Advantage, Inc.,...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Boehringer Ingelheim’s $13.53 billion asset swap with Paris-based Sanofi would likely be anticompetitive.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Abbott Laboratories’ $25 billion acquisition of St. Jude Medical, Inc. would likely be anticompetitive.
Federal Trade Commission Acting Chairman Maureen K. Ohlhausen announced today that she has appointed Abbott (Tad) Lipsky, a partner at the law firm of Latham & Watkins LLP, to be the Acting Director of the FTC’s Bureau of Competition, effective March 6, 2017.  
Energy infrastructure companies Enbridge Inc. and Spectra Energy Corp have agreed to settle Federal Trade Commission charges that the proposed merger of Enbridge and Spectra likely would harm competition in the market for pipeline transportation of natural gas in three production areas off the...
The Federal Trade Commission is accepting public comments on an application from SuperValu Inc. to sell one of two supermarkets it bought when Safeway and Albertsons merged in 2015 and were required by the agency to divest 168 stores.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Bausch + Lomb parent company Valeant Pharmaceuticals International, Inc. illegally acquired Paragon Holdings I, Inc.
The Federal Trade Commission filed a complaint in federal district court charging Shire ViroPharma Inc. (“ViroPharma”) with violating the antitrust laws by abusing government processes to delay generic competition to its branded prescription drug, Vancocin HCl Capsules. The complaint alleges that...
The newly released Remedy Study is the culmination of nearly two years of effort by FTC staff to look back at Commission merger orders from 2006 through 2012. We looked at 89 merger orders affecting 400 markets, with 79 divestitures to 121 buyers. We evaluated 50 of those orders...
A new Federal Trade Commission report, The FTC’s Merger Remedies 2006-2012: A Report of the Bureaus of Competition and Economics, finds that the agency’s process for maintaining competition when companies merge is generally effective.
The Federal Trade Commission has refiled a complaint and filed a proposed stipulated order in federal court to resolve charges that Endo Pharmaceuticals Inc.
With some exceptions, Section 8 of the Clayton Act prohibits the same individual from serving as an officer or director of two competing corporations. Like other portions of the forward-looking Clayton Act (including Section 7 with its proscription on mergers that are likely to harm...
For 2017, the size-of-transaction threshold for reporting proposed mergers and acquisitions under Section 7A of the Clayton Act will increase from $78.2 million to $80.8 million. The new 2017 thresholds under Section 8 of the Act that trigger prohibitions on certain interlocking memberships on...
OFTACOOP, a Puerto Rico ophthalmologist cooperative, has agreed to settle Federal Trade Commission charges that its actions harmed competition. The complaint charges that  OFTACOOP – also known as Cooperativa de Médico Oftalmólogos de Puerto Rico –  unlawfully orchestrated an agreement among...

Pages